We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$924M +$36.6M +163,542 +4%
BlackRock
2
BlackRock
New York
$906M +$2.95M +13,196 +0.3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$623M +$63.7M +284,870 +11%
ACA
4
Avoro Capital Advisors
New York
$613M -$9.73M -43,500 -1%
Renaissance Technologies
5
Renaissance Technologies
New York
$534M -$54.4M -243,377 -9%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$345M +$211M +941,837 +133%
State Street
7
State Street
Massachusetts
$334M +$5.55M +24,822 +2%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$284M -$21.8M -97,291 -7%
APM
9
Avidity Partners Management
Texas
$203M +$54.7M +244,600 +34%
PAI
10
Palo Alto Investors
California
$133M -$284K -1,272 -0.2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$132M -$1.18M -5,274 -0.8%
Citadel Advisors
12
Citadel Advisors
Florida
$129M +$124M +555,159 +935%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$128M -$6.34M -28,372 -4%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$127M -$39M -174,377 -22%
Millennium Management
15
Millennium Management
New York
$122M +$22.4M +100,312 +21%
LSV Asset Management
16
LSV Asset Management
Illinois
$118M -$5.79M -25,900 -4%
Fuller & Thaler Asset Management
17
Fuller & Thaler Asset Management
California
$115M -$22.8M -102,005 -16%
FCM
18
Farallon Capital Management
California
$115M +$35.1M +156,977 +40%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$111M +$933K +4,174 +0.8%
N
20
Nuveen
North Carolina
$107M +$1.44M +6,420 +1%
Norges Bank
21
Norges Bank
Norway
$87.9M +$2.72M +12,169 +3%
Swedbank
22
Swedbank
Sweden
$86.4M – – –
First Trust Advisors
23
First Trust Advisors
Illinois
$81.8M -$35.5M -158,712 -29%
PAMS
24
Pictet Asset Management (Switzerland)
Switzerland
$81.2M -$41.7M -186,603 -32%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$76.6M +$7.69M +34,412 +10%
1
2 3 4 5

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.